Pharmaceutical Contracts with Accession Option
Status
Active
Submission Deadline
433 days remaining
Contracting authority
BARMER Beschaffung und Vergabe24 more open tenders view
Location
Wuppertal, Germany
Procedure
Open Procedure · Supplies
Category
Pharmaceutical products.
Published
Reference
ted-584468-2026
Source
Pharmaceutical contracts with accession option: Procurement of pharmaceutical products containing the active ingredients or combinations of active ingredients specified in the title.
Free
Never miss a tender again
We send you 3 current matches that fit your company.
Tender documents
- Restricted — LOT-0001RESTRICTED-DOCUMENT
- TED HTML — 584468-2026HTML
- TED PDF — 584468-2026PDF
- TED XML — 584468-2026XML
Free
Unlock documents for free
Enter your email address. If you confirm, we will also send you 3 similar tenders.
Lots (38)
- LOT-0001Acemetacin (oral, retardiert)
- LOT-0002Baricitinib
- LOT-0003Beclometason dipropionat + Formoterol (DOS)
- LOT-0004Beclometason dipropionat + Formoterol (IHP_INH)
- LOT-0005Ciclosporin (ophthalmologisch, EDO)
- LOT-0006Clonazepam (ohne TEI)
- LOT-0007Dexamfetamin (ATC N06BA02)
- LOT-0008Eisencarboxymaltose (parenteral)
- LOT-0009Eletriptan
- LOT-0010Epoetin beta
- LOT-0011Epoetin theta
- LOT-0012Epoetin zeta
- LOT-0013Estradiol + Dienogest (ATC G03AB08)
- LOT-0014Follitropin alfa + Lutropin alfa
- LOT-0015Follitropin beta
- LOT-0016Folsäure (OTC, 5 mg, oral, ohne Kinder-AM)
- LOT-0017Glycopyrronium-Kation (inhalativ)
- LOT-0018Goserelin
- LOT-0019Granisetron (ILO)
- LOT-0020Granisetron (PFT)
- LOT-0021Interferon beta-1a (Avonex®)
- LOT-0022Natalizumab (i.v.)
- LOT-0023Natalizumab (s.c.)
- LOT-0024Pridinol (oral)
- LOT-0025Ranibizumab (Durchstechflaschen)
- LOT-0026Ranibizumab (Fertigspritzen)
- LOT-0027Rotigotin
- LOT-0028Safinamid (ausgenommen CYP450-Interaktionen + hERG-Kanal-blockierende Eigenschaften)
- LOT-0029Safinamid (Xadago®)
- LOT-0030Tinzaparin natrium
- LOT-0031Tiotropium-Kation (INL)
- LOT-0032Tobramycin (HPI)
- LOT-0033Tocilizumab (i.v.)
- LOT-0034Tocilizumab (s.c.)
- LOT-0035Treprostinil
- LOT-0036Triamcinolon acetonid (ATC D07AB09)
- LOT-0037Trientin dihydrochlorid
- LOT-0038Trientin tetrahydrochlorid
Additional details
EU Funded
Yes
Suitable for SMEs
No
Electronic Submission
Allowed
Legal Basis
32014L0024